FDA halts attention deficit disorder drug manufacture
• Associated PressThe FDA has withdrawn approval for a drug used to treat attention deficit hyperactivity disorder because it has been associated with liver problems, including death, but the FDA is allowing pharmacies to sell their remaining stock.